Otherside Farms

JANUARY 24, 2019

Federal regulators have approved two clinical studies testing whether a marijuana-based epilepsy drug may help prevent seizures among epileptic children. Source: FDA Approves Marijuana-Based Epilepsy Drug For Use On Kids In Clinical Trials. Although both studies will enroll 25 patients initially, the U.S. In the upcoming U.S.

Clinical Trials 45

Clinical Trials Epilepsy Marijuana Pharmaceutical 45

Medical Marijuana Program Connection

JANUARY 10, 2024

.–(BUSINESS WIRE)–Beginning in January 2024, natural medicine research nonprofits Realm of Caring, Unlimited Sciences and Lily’s Lighthouse will collaborate to collect data for an observational study on the efficacy of functional mushrooms in treating epilepsy. Read More

Epilepsy 40

Epilepsy Collective Data Medicine 40

SpeedWeed

MARCH 30, 2021

THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. However, with the database not yet available to the nation’s private clinics there are concerns over the quality and volume of data it will garner.

Data 52

Data Patients Clinical Trials Business 52

Canna Law Blog

NOVEMBER 29, 2019

Epidiolex is used to treat epilepsy and requires a prescription. I don’t doubt that the FDA based its above conclusions regarding Hemp-CBD on some set of studies or other data set, but it’s hard to justify the FDA making these claims without any reference to how the FDA reached these conclusions. Consumer Update. Conclusion.

Hemp 145

Hemp CBD Data Food 145

Cannabis Law Report

AUGUST 10, 2021

Commenting on the MHRA approval of GW’s cannabidiol, Tuberous Sclerosis Association (TSA) Chief Executive Louise Fish said: “One in every two people living with TSC-related epileptic seizures has difficult to treat epilepsy that does not respond to traditional anti-epileptic drugs. TSC is typically diagnosed in childhood. (5)

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Medical Marijuana Program Connection

JANUARY 5, 2024

“ data-action=”subscribe”> Subscribe We were unable to process. January 05, 2024 2 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on. Read More

Epilepsy 49

Epilepsy Treatment Topical Data 49

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. However, the scientific data on CBG is nowhere near as developed as what we have on CBD. Shutterstock). One of the leading cannabis clinicians in the U.S.,

CBD 122

CBD Research and Development Epilepsy Extraction 122

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Epilepsy Behav. Consumers spent roughly $31.3 increase in annual sales.

CBD 144

CBD Seed-To-Sale Food Access 144

Veriheal

NOVEMBER 18, 2022

Back in 2019 , the program was expanded to include ALL individuals with epilepsy—not just those with intractable epilepsy as the program had originally outlined. In September, the state expanded its list of qualifying conditions , allowing veterans with PTSD and cancer patients to join the program.

Edibles 98

Edibles Hemp Epilepsy Programs 98

The Cannigma

OCTOBER 21, 2021

As per usual, more data is needed. Epilepsy is the most obvious example, where the ketogenic diet has been applied for 100 years, cannabis has long been treated as is now also an FDA-approved treatment for a number of seizure disorders. The keto-canna connection: what do keto and cannabis have in common?

Cannabinoids 143

Cannabinoids Edibles Conditions Data 143

Cannabis Law Report

AUGUST 23, 2022

Spotlight PA sought that data to better understand the impact of the agency’s unusual and controversial decision to endorse cannabis as a treatment option for opioid use disorder. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy. It’s not clear whether the Department of Health will provide the data.

Data 52

Data Treatment Patients Chronic Pain 52

Cannabis Cheri

APRIL 1, 2022

In fact, a lot of people don’t realize that the keto diet was originally designed to treat seizures in children suffering from treatment resistant epilepsy. As always, more research and more data is needed to know for sure. Cannabis also famously helps in reducing seizures. They are both associated with lower inflammation levels.

Edibles 203

Edibles Cannabis Cannabinoids Oil 203

Illinois News Joint

JANUARY 9, 2025

Data suggests that cannabis can be helpful for women with difficulties or dysfunction attaining orgasm. IDPH provided the brief information about each condition below: Female orgasmic disorder This is a condition where a female has difficulty reaching orgasm. There may be a wide variety of causes for this syndrome.

Conditions 105

Conditions Treatment Chronic Pain Epilepsy 105

CannaTech

AUGUST 9, 2018

We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.

Strains 69

Strains Epilepsy Advocacy Medicine 69

The Cannigma

NOVEMBER 1, 2023

And along with research, real-world data can help us understand how topical products infused with minor cannabinoids could help with various aches and pains. That’s why Kriva is recruiting 150 Cannigma readers to try the Daily Wellness Body Lotion and report back on their experiences over a 4-week data collection period.

Topical 82

Topical Data Cannabinoids Terpenes 82

Cannabis Chronicles

JANUARY 2, 2019

drug regulators approved the first marijuana-based pharmaceutical to treat kids with a form of epilepsy, and billions of investment dollars poured into cannabis companies. Canada ushered in broad legalization, and Mexico’s Supreme Court set the stage for that country to follow. Legal marijuana was a $10.4 billion industry in the U.S.

Legalization 100

Legalization Research and Development Recreational Data 100

Cannabis Law Report

JULY 24, 2019

It will be the first to have meaningful and consistent data of how medicinal cannabis has helped when properly prescribed as part of a full treatment pathway.”

Epilepsy 40

Epilepsy Medicine Treatment Patients 40

TheAnswerPage

JULY 17, 2022

In 2017, researchers performed an analysis of observational clinical studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products. Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis Front. 12 September 2018.

Epilepsy 56

Epilepsy Extraction Treatment CBD 56

The Cannigma

JULY 17, 2022

Realm of Caring was founded in 2013 by two mothers whose children had epilepsy (the daughter of one of the founders was the namesake for Charlotte’s Web CBD.) The advice and suggestions are based on data, including the results from ROC’s own cannabis research registry.

Advocacy 120

Advocacy Education Events Epilepsy 120

Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Watch how Supera-CBD works. “We

Pharmaceutical 40

Pharmaceutical Data CBD Clinical Trials 40

Project CBD

MARCH 21, 2023

While animal studies have revealed that cannabinoid receptors likely have a role in modulating auditory signaling, there is no compelling data either from animal or human studies for the use of cannabinoids to alleviate tinnitus.” A review of the current literature.” And its conclusion?

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

Cannabis Law Report

SEPTEMBER 12, 2021

For several millennia, humans have used cannabinoids for pain, epilepsy, gastrointestinal disorders, and even infections. We need to see data demonstrating the differences in oral bioavailability among these different compounds.”. Cats are more challenging. I am excited about CBD,” she said. “I I think it’s a very safe compound.

Patients 105

Patients Pets Seed-To-Sale Cannabinoids 105

Sensi Seeds

DECEMBER 10, 2018

They evaluate data, which is now available thanks to the efforts of the cannabis policy reform movement, and try to provide answers, especially to those who need them most, namely, medical patients. It seems as though research on cannabis and cannabinoids is taking such large strides that it even surpasses research growth in other fields.

Medicine 81

Medicine Research and Development Data Policy 81

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

Even doses higher than 1,000mg have been safely administered in testing, and CBD is considered safe for children for the treatment of epilepsy. In fact, the US Food and Drug Administration recently approved the first marijuana-derived drug , Epidiolex, for the treatment of atypical epilepsy in children known as Dravet Syndrome.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Cannabis Law Report

DECEMBER 1, 2019

A young girl with a drug-resistant form of epilepsy is believed to be the first and only patient in Singapore who has been given approval to use cannabis-derived medication. The move follows approvals by lawmakers in the United States to use the medication to treat rare kinds of childhood epilepsy in that country.

Epilepsy 45

Epilepsy Cannabinoids Therapy Treatment 45

CannaTech

SEPTEMBER 23, 2019

The group’s misguided conclusions are a strawman: prohibition of cannabis and the requirements of Helsinki have severely limited research into the plant’s potential medical applications, ergo less gold-standard randomized controlled clinical trial data. We have seen first-hand how cannabis saves lives and improves quality of life.

Patients 79

Patients Policy Clinical Trials Research and Development 79

LifeCannMD

JANUARY 2, 2025

A comprehensive review published in JAMA Oncology examined clinical data and case reports on cannabis as an anticancer agent. However, scientific research has not substantiated these claims.

Oil 98

Oil Concentrates Treatment Chronic Pain 98

Cannabis Law Report

JUNE 5, 2019

The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Today (30 May) at 09.30 The organization will focus on the use of special treatment schemes.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

TheAnswerPage

JULY 19, 2022

Have researchers found that patients who use cannabidiol (CBD)-rich extract therapy for the treatment of epilepsy require a lower dose of CBD medication as compared to those who use purified CBD therapy for the treatment of epilepsy? Pamplona F, da Silva L and Coan A. 12 September 2018. Sec.Neuropharmacology. See the Answer.

Epilepsy 40

Epilepsy Therapy Extraction Data 40

The Joint Blog

JULY 17, 2020

According to a new study published in the journal Seminars in Pediatric Neurology, marijuana-based products are associated with improvements in the symptoms of autistic patients who have self-injurious behaviors and co-morbid epilepsy. Those diagnosed with both ASD and epilepsy saw a 91% seizure control improvement.

Epilepsy 47

Epilepsy Research and Development Marijuana Treatment 47

Freedom Leaf

OCTOBER 15, 2018

On the basis of their review, the agency approved Epidiolex for use in treating rare forms of childhood epilepsy (Lennox-Gastaut syndrome and Dravet syndrome). Frontier Data predicts total sales of all CBD products in the U.S. Frontier Data predicts total sales of all CBD products in the U.S. will top $1.9 billion by 2022.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

TheAnswerPage

JULY 18, 2022

In 2017, researchers performed an analysis of observational studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products and reported on the side effects of the CBD products: “The reports of mild (158/216, 76% vs. 148/447, 33%, p. Pamplona F, da Silva L and Coan A.

Epilepsy 40

Epilepsy Therapy Extraction Treatment 40

Cannabis Law Report

AUGUST 17, 2021

Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 76

Pharmaceutical Clinical Trials Treatment Patients 76

Cannabis Law Report

DECEMBER 7, 2021

This trend is also observed in the pediatric population, where MCs are authorized in children for refractory epilepsy, especially in Dravet syndrome and Lennox-Gastaut syndrome 2. A systematic review published in 2017 aimed to identify available data about the therapeutic effect of cannabinoids treatment in children and adolescents.

Safety 52

Safety Cannabinoids Data Events 52

Veriheal

APRIL 11, 2022

We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds. This means that U.S.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

TheAnswerPage

MAY 31, 2021

American Epilepsy Society (AES): Written Comments to Norman E. Food and Drug Administration (FDA), Department of Health and Human Services (HHS): on Docket ID# FDA-2019-N-1482, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds; Public Hearing; Request for Comments: Submitted on: July 16, 2019.

Epilepsy 40

Epilepsy Food Data Oil 40

Veriheal

DECEMBER 28, 2021

This is according to recent data from a report published by Market Research Future (MRT) – a pioneer in market analysis. It is because of the dedication of advocates and scientists that the medical cannabis industry is expected to generate a compound annual growth rate (CAGR) of 1 8.4% Amyotrophic lateral sclerosis (ALS). Alzheimer’s.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98